Related Experiment Video
Updated: Aug 19, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis
Jasmin Bektic1, Karina Pfeil, Andreas Paul Berger
1Department of Urology, University of Innsbruck, Innsbruck, Austria. jasmin.bektic@uibk.ac.at
Background:
RhoE/Rnd3, a recently described novel member of the Rho GTPases family, was discussed as a possible antagonist of the RhoA protein that stimulates cell cycle progression and is overexpressed and/or overactivated in prostate cancer. We investigated the expression of RhoE and its role in cell cycle regulation and apoptosis in the human prostate.
Methods:
RhoE expression in cell lines and tissue specimens was assessed by immunoblot analysis, real-time PCR (RT-PCR), and immunohistochemistry. To elucidate RhoE effects on the prostate, RhoE was cloned and overexpressed in DU-145 prostate cancer. Cell cycle modulation and apoptosis was investigated by immunoblot and FACS analysis.
Results:
Immunoblot analysis showed a strong RhoE signal in both, benign epithelial and stromal cells. In contrast, almost no protein was detected in various prostate cancer cells. On RT-PCR and microarray analysis, RhoE mRNA expression was significantly reduced in malignant tissue when compared to benign samples. RhoE immunostaining was strong in benign tissue, especially in prostate epithelial cells, whereas it was minimal or absent in malignant tissue. Forced RhoE overexpression in a prostate cancer cell line inhibits the expression of two proteins essential for G2/M transition, namely CDC2 and cyclin B1, and induces G2/M arrest. In addition, apoptotic cell death as measured by a cleavage product of caspase 3 is significantly increased in RhoE-overexpressing cells.
Conclusion:
In conclusion, our findings suggest RhoE as a tumor suppressor gene that is downregulated early in the development of prostate cancer.
Insights
RhoE is downregulated in prostate cancer, acting as a tumor suppressor. Overexpressing RhoE inhibits cancer cell growth and promotes apoptosis, suggesting its early role in prostate cancer development.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- RhoE/Rnd3, a Rho GTPase, may antagonize RhoA, which promotes cell cycle progression and is implicated in prostate cancer.
- Investigated RhoE expression and function in prostate cancer cell cycle regulation and apoptosis.
Purpose of the Study:
- To investigate RhoE expression in prostate cancer.
- To determine the role of RhoE in prostate cancer cell cycle regulation and apoptosis.
Main Methods:
- Assessed RhoE expression using immunoblot, RT-PCR, and immunohistochemistry in prostate cell lines and tissues.
- Overexpressed RhoE in DU-145 prostate cancer cells.
- Analyzed cell cycle and apoptosis via immunoblot and FACS analysis.
Main Results:
- RhoE protein and mRNA expression were significantly reduced in prostate cancer tissues compared to benign tissues.
- Forced RhoE overexpression in cancer cells inhibited CDC2 and cyclin B1, induced G2/M arrest, and increased apoptosis.
- RhoE was strongly expressed in benign prostate epithelial cells but minimally or absent in malignant cells.
Conclusions:
- RhoE functions as a tumor suppressor gene in the prostate.
- RhoE downregulation occurs early in prostate cancer development.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
GTPases and their Regulation
Large G-proteins, also known...
Negative Regulator Molecules
Activation and Inactivation of G Proteins
Amplifying Signals via Enzymatic Cascade
The Ras Gene
Ras is a superfamily...

